Transcode Therapeutics is based in Boston, MA. It has raised $45M in total funding. Latest round: Growth.
Transcode Therapeutics is based in Boston, MA. Transcode Therapeutics has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in April 2026. The round record for Transcode Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include CK Life Sciences Int'l., Institutional healthcare investor. 2 distinct backers are named across the disclosed rounds.
Every Transcode Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.
The investor deck Transcode Therapeutics used to raise — 2022, Public (NASDAQ: RNAZ), 44-slide deck is broken down slide by slide, including the slides it leads with and the questions it leaves open.
Company funding database · Investor directory · Founder database · Mega-rounds 2026